Summit Creek Advisors’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-131,860
| Closed | -$8.34M | – | 75 |
|
|
2022
Q1 | $8.34M | Buy |
131,860
+503
| +0.4% | +$31.8K | 0.94% | 43 |
|
|
2021
Q4 | $6.97M | Buy |
131,357
+3,574
| +3% | +$190K | 0.7% | 47 |
|
|
2021
Q3 | $9.02M | Buy |
127,783
+10,736
| +9% | +$758K | 0.95% | 46 |
|
|
2021
Q2 | $7.8M | Sell |
117,047
-4,315
| -4% | -$288K | 0.93% | 48 |
|
|
2021
Q1 | $13.5M | Sell |
121,362
-1,588
| -1% | -$176K | 1.61% | 36 |
|
|
2020
Q4 | $14.6M | Sell |
122,950
-7,560
| -6% | -$898K | 1.87% | 29 |
|
|
2020
Q3 | $11.4M | Buy |
130,510
+2,910
| +2% | +$254K | 1.69% | 29 |
|
|
2020
Q2 | $11.4M | Buy |
+127,600
| New | +$11.4M | 1.68% | 24 |
|